Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B03BB01	FOLICIL	G	Folic acid - 5mg	5mg	Tablet	584,571 L.L
C01BC04	FLECAINE	B	Flecainide acetate - 100mg	100mg	Tablet, scored	878,873 L.L
C01BC04	FLECAINIDE ARROW LAB	G	Flecainide acetate - 100mg	100mg	Tablet, scored	588,603 L.L
C01BC04	FLECAINIDE BIOGARAN L.P.	G	Flecainide acetate - 100mg	100mg	Capsule, extended release	1,154,361 L.L
C01BC04	FLECAINIDE BIOGARAN L.P.	G	Flecainide acetate - 50mg	50mg	Capsule, extended release	1,154,361 L.L
C03BA11	FLUDEX	B	Indapamide - 1.5mg	1.5mg	Tablet, sustained release	517,379 L.L
C03CA01	FURESIX 40	G	Furosemide - 40mg	40mg	Tablet	166,381 L.L
C03CA01	FUROSETIC	G	Furosemide - 40mg	40mg	Tablet, scored	121,586 L.L
C03CA01	FRURETIC	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	2,600,655 L.L
C03CA01	FUROLIX	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	1,612,611 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	451,531 L.L
C03CA01	FUROSEMIDE SALF	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	216,359 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	1,791,342 L.L
C03CA01	FUROSEMIDE S.A.L.F.	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	919,188 L.L
C10AB05	FENOFIBRATE ARROW	G	Fenofibrate - 160mg	160mg	Tablet	639,669 L.L
C10AB05	FENOSUP LIDOSE	G	Fenofibrate - 160mg	160mg	Capsule	774,053 L.L
C10AB05	FINOFIB BENTA	G	Fenofibrate - 160mg	160mg	Tablet, film coated	788,388 L.L
C10AB05	FINACOR	G	Fenofibrate micronised - 160mg	160mg	Capsule	774,309 L.L
C10AB05	FENOGAL	G	Fenofibrate micronised - 200mg	200mg	Capsule, micronized	392,402 L.L
D04AA13	FENISTIL	B	Dimethindene maleate - 1mg/g	1mg/g	Gel	196,201 L.L
D06AX01	FUCIDIN	B	Fusidic acid - 20mg/g	2%	Cream	259,362 L.L
D06AX01	FUCIDIN CREAM	B	Fusidic acid - 2%	2%	Cream	491,846 L.L
D06AX01	FUCIDIN CREAM	B	Fusidic acid - 2%	2%	Cream	345,368 L.L
D06AX01	FUTASOLE	G	Fusidic acid - 20mg/g	2%	Cream	145,135 L.L
D06AX01	FUCIDIN	B	Fusidic acid (sodium salt) - 20mg/g	2%	Ointment	259,362 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	491,846 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	345,368 L.L
D06AX01	FUCIKALT	G	Fusidic acid (sodium salt) - 2%	2%	Ointment	209,895 L.L
D07AC04	FLUOCINOLONE ACETONIDE	G	Fluocinolone acetonide - 0.25mg/g	0.25mg/g	Cream	296,925 L.L
D07CC01	FUCICORT	B	Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g		Cream	376,276 L.L